AD is characterized from a pathological point of view by two pathognomonic lesions: 1/extracellular plaques of insoluble β-amyloid peptides (Aβ) and 2/neurofibrillary tangles composed of hyperphosphorylated tau protein (p-tau) in neural cytoplasm. The gene discussed is MAPT; the disease is Alzheimer disease.